Prevention of Asthma With Levocetirizine 18 Month Treatment in Infants (12 - 24 Months) Suffering From Eczema (Atopic Dermatitis) and Sensitized to Grass Pollen and/or House Dust Mite (HDM)

NCT00152464 PHASE3 COMPLETED Results posted

The Early Prevention of Asthma in Atopic Children (EPAAC™). 24 months study to evaluate the efficacy and safety of levocetirizine (LCTZ) in preventing the onset of asthma in 12 to 24 months old children.

Details

Lead sponsor	UCB Pharma SA
Phase	PHASE3
Status	COMPLETED
Enrolment	514
Start date	Wed Mar 20 2002 00:00:00 GMT+0000 (Coordinated Universal Time)
Completion	Wed Mar 15 2006 00:00:00 GMT+0000 (Coordinated Universal Time)

Conditions

• Dermatitis, Atopic

Interventions

• Placebo
• Levocetirizine